Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System

NCT05406856 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05406856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 2, 2022
Completion date
December 1, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cervical carcinoma, uterine cervical neoplasms